BeOne insider plans sale of 132 ADS on NASDAQ
BeOne Medicines Ltd. (ONC) discloses that Titus Benjamin Ball plans to sell 132 American Depositary Shares (ADS) of the company under Rule 144, following restricted stock vesting under a registered plan.
Rhea-AI Filing Summary
BeOne Medicines Ltd. (ONC) discloses that Titus Benjamin Ball plans to sell 132 American Depositary Shares (ADS) of the company under Rule 144, following restricted stock vesting under a registered plan. The planned sale is to be executed through Morgan Stanley Smith Barney LLC on NASDAQ. Over the prior three months, Titus Benjamin Ball reported sales of 169 ADS on June 11, 2026 for $43,466.56 and 136 ADS on June 8, 2026 for $36,900.64.
Positive
- None.
Negative
- None.
Key Figures
Planned ADS to be sold: 132 ADS
ADS sold on June 11, 2026: 169 ADS for $43,466.56
ADS sold on June 8, 2026: 136 ADS for $36,900.64
+2 more
5 metrics
Planned ADS to be sold
132 ADS
Intended Rule 144 sale by Titus Benjamin Ball
ADS sold on June 11, 2026
169 ADS for $43,466.56
Sales during the past 3 months
ADS sold on June 8, 2026
136 ADS for $36,900.64
Sales during the past 3 months
Planned sale exchange
NASDAQ
Intended trading market for the ADS transaction
Broker
Morgan Stanley Smith Barney LLC
Executing broker for the planned Rule 144 sale
Key Terms
Rule 144, restricted stock, American Depositary Shares (ADS)
3 terms
Rule 144 regulatory
"See the definition of "person" in paragraph (a) of Rule 144."
Rule 144 is a U.S. securities regulation that sets conditions under which restricted or insider-held shares can be legally resold to the public, such as required holding periods, availability of public information, limits on how much can be sold at once, and certain filing requirements. For investors it matters because it determines when previously locked-up shares can enter the market — like a release valve that can increase supply, affect share price, and signal insider intent.
restricted stock financial
"Restricted Stock Vesting Under a Registered Plan"
Shares granted to an individual that carry limits on transfer or sale until certain conditions are met, such as staying with the company for a set time or hitting performance targets. Think of them as a locked gift that gradually opens; for investors they matter because they affect how many shares may enter the market later, signal management incentives and potential dilution, and reveal confidence in future company performance.
FAQ
What does the Form 144 filing disclose for BeOne Medicines Ltd. (ONC)?
It discloses that Titus Benjamin Ball intends to sell 132 ADS of BeOne Medicines Ltd. under Rule 144, related to restricted stock vesting under a registered plan, with sales to be executed through Morgan Stanley Smith Barney LLC on NASDAQ.
How many BeOne Medicines (ONC) ADS are planned to be sold under this Form 144?
The filing states an intended sale of 132 ADS of BeOne Medicines Ltd. The securities are described as restricted stock vesting under a registered plan and are to be sold pursuant to Rule 144.
Which broker is handling the planned Rule 144 sale for ONC ADS?
The planned Rule 144 sale of BeOne Medicines Ltd. (ONC) ADS is to be handled by Morgan Stanley Smith Barney LLC, Executive Financial Services, located at 1 New York Plaza, New York, with the ADS listed for trading on NASDAQ.
What prior sales by Titus Benjamin Ball in ONC ADS are disclosed in the last 3 months?
The filing lists two prior sales: on June 11, 2026, 169 ADS were sold for $43,466.56, and on June 8, 2026, 136 ADS were sold for $36,900.64, both involving BeOne Medicines Ltd. ADS.
What is the nature of the securities being sold for BeOne Medicines (ONC)?
The securities are American Depositary Shares (ADS) of BeOne Medicines Ltd., arising from restricted stock vesting under a registered plan. The planned disposition is reported under Rule 144 for the account of Titus Benjamin Ball.
AI-generated analysis. How Rhea-AI works. Not financial advice.